Related Experiment Video
Updated: Mar 19, 2026
11:56
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
13.1K
The development of antimicrobial γ-AApeptides.
Fengyu She1, Olapeju Oyesiku1, Peiguang Zhou2
1Department of Chemistry, University of South Florida, 4202 E. Fowler Ave, Tampa, FL 33620, USA.
Future Medicinal Chemistry
|June 11, 2016
Summary
New antimicrobial peptidomimetics, called gamma-AApeptides, show potent activity against drug-resistant bacteria. These compounds overcome limitations of host-defense peptides, offering a promising alternative for future antibiotic development.
Area of Science:
- Medicinal Chemistry
- Antimicrobial Peptides
- Drug Discovery
Background:
- Host-defense peptides (HDPs) are crucial in innate immunity and show promise as antibiotics due to their membrane-disrupting mechanism.
- HDPs face challenges including limited activity and susceptibility to enzymatic degradation, hindering their clinical application.
- Emerging antibiotic resistance necessitates the development of novel antimicrobial agents.
Purpose of the Study:
- To review the development and antimicrobial potential of a novel class of peptidomimetics, gamma-AApeptides.
- To highlight the advantages of gamma-AApeptides over traditional HDPs, including enhanced stability and broad-spectrum activity.
- To discuss the future prospects of gamma-AApeptides as next-generation antimicrobial agents.
Main Methods:
- Development of gamma-AApeptides through straightforward synthetic routes.
- Evaluation of antimicrobial activity against a panel of Gram-positive and Gram-negative multidrug-resistant bacteria.
- Assessment of resistance to proteolysis compared to natural HDPs.
Main Results:
- Gamma-AApeptides demonstrate potent and broad-spectrum bactericidal activity.
- These peptidomimetics exhibit superior resistance to enzymatic degradation compared to natural HDPs.
- Gamma-AApeptides effectively mimic the membrane-disrupting mechanism of HDPs.
Conclusions:
- Gamma-AApeptides represent a promising class of antimicrobial peptidomimetics with significant potential.
- Their enhanced stability and potent activity offer a viable strategy to combat multidrug-resistant bacterial infections.
- Further development of gamma-AApeptides could lead to novel therapeutic agents against challenging pathogens.
Keywords:
antibiotic resistanceantimicrobial activityhost-defense peptidespeptidomimeticsγ-AApeptidesMore Related Videos
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
12.9K
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
12.5K
Related Concept Videos
01:23Antimicrobial Proteins
15.2K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.2K
01:23Inhibitors of Gram-positive Cell Wall Synthesis
8
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
8
01:30Development of Antibiotic Resistance
1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
01:28Peptidoglycan Synthesis
3.9K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
3.9K
01:26Bacterial Protein Maturation
679
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
679
01:30Production of Pharmaceuticals
4
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
4